Mashed potatoes and maize: Are the starches safe?

Anesthesiology

Volumn 118, Issue 2, 2013, Pages 244-246

  Bagchi, Aranya ^a   Eikermann, Matthias ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HETASTARCH; PHOSPHATE; SODIUM CHLORIDE;

ACUTE LUNG INJURY; CHEMICAL STRUCTURE; CREATININE BLOOD LEVEL; CRYSTALLOID; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FLUID RESUSCITATION; HEMORRHAGIC SHOCK; HUMAN; HYPOVOLEMIA; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY INJURY; MAIZE; META ANALYSIS (TOPIC); MICROCIRCULATION; MOLECULAR WEIGHT; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; POTATO; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS; SEPTIC SHOCK; VISCOSITY;

ACUTE LUNG INJURY; ANIMALS; FEMALE; KIDNEY; LUNG; PLASMA SUBSTITUTES;

EID: 84872840798     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31827e5582     Document Type: Review

References (19)

1. Latta T: Saline venous injection in cases of malignant cholera, performed while in the vapour-bath. Lancet 1832; 19:173-6
2. Hogan JJ: The intravenous use of colloidal (gelatin) solutions in shock. JAMA 1915; 64:721-6
3. Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, Du B, McArthur C, Myburgh J; SAFE TRIPS Investigators: Resuscitation fluid use in critically ill adults: An international cross-sectional study in 391 intensive care units. Crit Care 2010; 14:R185
4. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet): Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-39
5. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group: Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124-34
6. Silva PL, Guldner A, Uhlig C, Carvalho N, Beda A, Rentzch I, Kasper M, Wiedemann B, Spieth PM, Koch T, Capelozzi VL, Pelosi P, Rocco PRM, de Abreu MG: Effects of intravascular volume replacement on lung and kidney function and damage in nonseptic experimental lung injury. Anesthesiology 2013; 118:395-408
7. Martin C, Jacob M, Vicaut E, Guidet B, Von Aken H, Kurz A: Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013; 118:387-94
8. Mizzi A, Tran T, Karlnoski R, Anderson A, Mangar D, Camporesi EM: Voluven, a new colloid solution. Anesthesiol Clin 2011; 29:547-55
9. Tabata S, Hizukuri S: Studies on starch phosphate. Part 2. Isolation of glucose 3-phosphate and maltose phosphate by acid hydrolysis of potato starch. Starch/Starke 1971; 23:267-72
10. Godet MC, Tran V, Colonna P, Buleon A: Inclusion/exclusion of fatty acids in amylose complexes as a function of the fatty acid chain length. Int J Biol Macromol 1995; 17:405-8
11. Ertmer C, Rehberg S, Van Aken H, Westphal M: Relevance of non-albumin colloids in intensive care medicine. Best Pract Res Clin Anaesthesiol 2009; 23:193-212
12. Hartog CS, Kohl M, Reinhart K: A systematic review of thirdgeneration hydroxyethyl starch (HES 130/0.4) in resuscitation: Safety not adequately addressed. Anesth Analg 2011; 112:635-45
13. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-56
14. Chappell D, Jacob M: Protocols, physiology, and trials of hydroxyethyl starch. N Engl J Med 2012; 367:1266; author reply 1267
15. James MF, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS: Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: The FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011; 107: 693-702
16. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H: Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012; 16:R94
17. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; the CHEST Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group: Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-11
18. Van Der Linden P, James M, Mythen M, Weiskopf RB: Safety of Modern Starches Used During Surgery. Anesth Analg 2012; DOI: 10.1213/ANE. 0b013e31827175da
19. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P: Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348:1620-2